Search
for
Sort by
Research 61–90 of 66
- Cardiovascular Risk Factors in Bulgarian Patients with Polycystic Ovary Syndrome and/or Obesity
- Association of severity of menstrual dysfunction with cardiometabolic risk markers among women with polycystic ovary syndrome
- Role of low dose oral minoxidil in the treatment of hair loss: A review
- Prevalence, Symptomatology and Herbal Management of Polycystic Ovarian Syndrome
- Approach to the Patient: Diagnostic Challenges in the Work Up for Polycystic Ovary Syndrome
- Comparison of the Effect of Auriculotherapy, a Herbal Compound (Aslagh Capsule), and Metformin on the Clinical Symptoms of Polycystic Ovary Syndrome: Randomized Clinical Trial
- Pre‐polycystic ovary syndrome and polymenorrhoea as new facets of polycystic ovary syndrome (PCOS): Evidences from a single centre data set
- Spironolactone Reduces Facial and Body Hair in Women with Hirsutism
- <i>Serenoa repens</i> as an Endocrine Disruptor in a 10-Year-Old Young Girl: A New Case Report
- Spironolactone in the Treatment of Hirsutism
- The relationship between coronavirus disease 2019 (COVID-19) vaccines, abnormal uterine bleeding, and hormonal disorders in women of reproductive age: one-center cross-sectional results
- [PRACTICAL EXPERIENCES WITH OVULATION INHIBITION].
- Comparison of Clinical and Biochemical Markers of Hirsutism in Polycystic Ovary Syndrome – A Study from a Teaching Hospital in Sri Ramachandra Institute, Chennai, India
- Menstrual Irregularity in Women with Acromegaly
- Ameliorative effects of rutin against metabolic, biochemical and hormonal disturbances in polycystic ovary syndrome in rats
- Long-Term Response of Hirsutism and Other Hyperandrogenic Symptoms to Combination Therapy in Polycystic Ovary Syndrome
- USE OF SPIRONOLACTONE IN COMBINATION WITH AN ORAL CONTRACEPTIVE IN TREATMENT OF HIRSUTISM
- Polycystic ovary syndrome
- Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management
- Signal Mining for Non-Bleeding Adverse Event in Novel Oral Anticoagulants: A Pharmacovigilance Study Based on the FAERS Database
- Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
- American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1
- Genetic, hormonal and metabolic aspects of PCOS: an update
- Polycystic Ovary Syndrome
- Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review
- Hormonal contraceptives: pharmacology tailored to women's health
- Therapeutic approach for metabolic disorders and infertility in women with PCOS
- Polycystic Ovary Syndrome and Its Differential Diagnosis
- Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism
- Relative Safety and Efficacy of Finasteride for Treatment of Hirsutism